Anavex Life Sciences Corp (NASDAQ:AVXL)

17.98
Delayed Data
As of Oct 15
 0.00 / 0.00%
Today’s Change
4.51
Today|||52-Week Range
31.50
+232.96%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Operating ActivitiesNet Income / Starting Line-12.1M-14.7M-13.5M-17.5M
 
 
 
 
 
Depreciation995.001.3K0.000.00
 
 
 
Total Other Cash Flow6.6M4.9M4.1M5.5M
 
 
 
 
 
Funds From Operations-5.5M-9.9M-9.4M-11.9M
 
 
 
 
 
Funds From/For Other Operating Expenses-1.2M-640.1K-382.8K646.0K
 
 
 
 
 
Net Cash Flow - Operating Activities-4.2M-9.2M-9.0M-12.6M
 
 
 
 
 
 
InvestingNet Cash Flow Investing0.000.000.000.00--
 
FinancingShort Term Borrowings-88.1K-34.8K0.000.00
 
 
 
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction0.000.000.000.00--
Net Proceeds Stock Sale12.3M3.2M27.3M8.2M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.00101.1K
 
 
Net Cash Flow - Financing12.3M3.1M27.3M8.1M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash----------
 
Net Change In Cash8.0M-6.1M18.3M-4.5M